Skip to main content
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Our Founders
    • Our Team
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes celebrate extraordinary achievements in the arts and sciences.

    • About the Prizes
    • Prize Recipients
    • Vilcek Prizes

      Awards immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Recognizes young immigrant professionals for outstanding achievements.

    • Vilcek Prize for Excellence

      Celebrating intellectual and cultural leaders in the United States.

    • Marica Vilcek Prize in Art History

      Honors art historians, curators, and fine arts professionals.

  • Art
  • Grants
    • Grants

      Grants awarded to 501(c)(3) cultural, educational, and philanthropic organizations in the United States.

    • Grants

      Learn more and apply for a grant.

    • Grants History

      Explore a list of past Vilcek Foundation grantees.

  • Events
  • News
Sign Up Search
Home > News > Vilcek Foundation awards $100,000 prize to Dr. Katalin Karikó, immigrant scientist who pioneered mRNA vaccine technology

Vilcek Foundation awards $100,000 prize to Dr. Katalin Karikó, immigrant scientist who pioneered mRNA vaccine technology

Press Release | June 8, 2021
Download Press Release PDF
Tags
biotechnology covid-19 rna vilcek prize vilcek prize for excellence
Share this page
Share this page on X Share this page on Facebook Share this page on LinkedIn

Portrait of Dr. Katalin Karikó.

Dr. Katalin Karikó is the recipient of the 2022 Vilcek Prize for Excellence in Biotechnology recognizing her research work that directly led to the development of the mRNA vaccines to combat COVID-19.

The Vilcek Prize for Excellence is awarded to immigrants to the United States who have had a significant impact on both American society and world culture, and to individuals who are dedicated champions of immigrant causes. The award was introduced in 2019 as part of the Vilcek Foundation Prizes program to honor outstanding individuals whose work exemplifies the Vilcek Foundation’s mission.

Born in Szolnok, Hungary, Karikó moved to the United States in 1985 to pursue postdoctoral studies at Temple University in Philadelphia. She is the senior vice president at BioNTech RNA Pharmaceuticals and an adjunct associate professor of neurosurgery at the University of Pennsylvania.

“Dr. Karikó’s pioneering work is responsible for the development of novel vaccines against COVID-19,” says Vilcek Foundation Cofounder, Chairman and CEO Jan Vilcek. “This formidable accomplishment, based on four decades of her research on the therapeutic use of messenger RNA, promises to stop the worldwide spread of COVID-19 and save millions of lives.”

In the mid-2000s, working with immunologist Drew Weissman, Karikó demonstrated that modifying nucleosides—the building blocks of messenger RNA (mRNA)—renders mRNA safe for use in vaccination against infectious agents. At the time, researchers were pessimistic about the prospect of mRNA vaccines; synthetic mRNA that has not been modified is inherently fragile, and can trigger a serious inflammatory response when introduced to the human immune system. In groundbreaking studies, Karikó showed that using the pseudouridine instead of uridine to create synthetic mRNA not only averts adverse immune reactions but also boosts the molecule’s stability and protein yield.

Katalin Karikó sits in her home office dressed in a black blazer.
Katalin Karikó, a senior vice president at BioNTech overseeing its mRNA work, in her home office in Rydal, Pennsylvania. Photo courtesy of Katalin Karikó & Jessica Kourkounis/The Boston Globe

Karikó’s breakthrough on the stabilizing effect of modifying nucleosides in mRNA enabled scientists to develop mRNA vaccines for COVID-19, most notably those developed by Pfizer and Moderna. The vaccines have shown more than 94% efficacy in preventing symptomatic disease in clinical trials and are now being deployed across the United States to turn the tide on the pandemic.

“The Vilcek Prize for Excellence was conceived to honor individuals whose contributions benefit society on a broad level,” says Marica Vilcek, Vilcek Foundation Cofounder, Vice Chairman and Secretary. “Dr. Karikó’s work has obviously had a tremendous impact on science and medicine—but the development of mRNA vaccines based on her research also has a profound humanitarian significance. In enabling people and communities to return to normal activities and to connect with one another in person, her work has had a direct positive impact on global society.”

The Vilcek Prize for Excellence is awarded as part of the Vilcek Foundation Prizes program. Recipients of the prize receive a cash award of $100,000 and a commemorative diploma. In recognition of the profound impact of Karikó’s work at the current moment, the Vilcek Foundation made the decision to announce the 2022 Vilcek Prize for Excellence in advance of the rest of the 2022 Vilcek Foundation Prizes. The recipients of the 2022 Vilcek Foundation Prizes in Biomedical Science and Dance will be announced on September 7, 2021.

Tags
biotechnology covid-19 rna vilcek prize vilcek prize for excellence
Share this page
Share this page on X Share this page on Facebook Share this page on LinkedIn

Related News

March 29, 2022

Katalin Karikó: The sacrifices and successes of immigrant scientists

Amid multiple awards for the development of mRNA vaccines, Hungarian biochemist Katalin Karikó insists that her greatest success has been being able to show up every day for a career she is passionate about.
Katalin Karikó standing in the woods in a beige coat with fur trim.
September 7, 2021

Announcing the 2022 Vilcek Foundation Prizewinners

The Vilcek Foundation awards $600,000 in prizes to outstanding immigrant leaders in biomedical science and in dance.
June 8, 2021

Dr. Katalin Karikó receives 2022 Vilcek Prize for Excellence for pioneering vaccine research

The 2022 Vilcek Prize for Excellence in Biotechnology is awarded to Dr. Katalin Karikó for her research discoveries that rendered mRNA vaccines for COVID-19 possible.

You may also be interested in

Katalin Karikó

Katalin Karikó receives the Vilcek Prize for Excellence in Biotechnology for her pioneering research leadership into the development of mRNA therapeutics, which led to the development of mRNA vaccines for COVID-19.
Portrait of Katalin Karikó

Luciano Marraffini

Luciano Marraffini receives the Vilcek Prize in Biomedical Science for uncovering the molecular mechanisms by which CRISPR-Cas systems provide bacteria with adaptive immunity against viral infections, and for his investigations into applications of CRISPR-Cas for genome editing.
A portrait of Luciano Marraffini wearing blue-rimmed glasses.

Silvi Rouskin

Silvi Rouskin receives the Vilcek Prize for Creative Promise in Biomedical Science for developing methods to unravel the shapes of RNA molecules inside cells and aiding the potential development of RNA-based therapeutics.
Portrait of Silvi Rouskin

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Our Founders
    • Our Team
    • Press Center
    • Contact
  • Prizes
    • Prize Recipients
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Marica Vilcek Prize in Art History
  • Art
  • Grants
    • Grants History
  • Events
  • News
  • Careers
Connect with us
  • Connect with the Vilcek Foundation on Facebook
  • Connect with the Vilcek Foundation on Instagram
  • Connect with the Vilcek Foundation on X
  • Connect with the Vilcek Foundation on LinkedIn
  • Connect with the Vilcek Foundation on Youtube
  • Connect with the Vilcek Foundation on Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2025   Vilcek Foundation
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok